Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
about
Basal cell carcinomaBasal cell carcinoma: 10-year experience with electrochemotherapy.Curettage, electrosurgery and skin cancer.A reliable frozen section technique for basal cell carcinomas of the head and neck.Mohs micrographic surgery for facial skin cancer.Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.Patient-reported outcomes of electrodessication and curettage for treatment of nonmelanoma skin cancer.[Basal cell basal cell epithelioma of the face: surgical management, about 45 cases and review of the literature]Treatment of facial Basal cell carcinoma: a review.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm MeetingMohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.Mohs surgery: commentaries and controversies.Current modalities and new advances in the treatment of basal cell carcinoma.Clinicopathological analysis of recurrent basal cell carcinoma of the eyelidGuidelines for the management of basal cell carcinoma.Incompletely excised basal cell carcinomas: Our guidelines.Basal cell carcinoma: evidence-based medicine and review of treatment modalities.Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening.Basal cell carcinoma. Choosing the best method of treatment for a particular lesion.Focus on Basal cell carcinoma.Systemic therapy for inoperable and metastatic basal cell cancer.Radiotherapy of carcinomas of the skin overlying the cartilage of the nose: our experience in 671 lesions.Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.Treatment of basal cell carcinoma in Scandinavia: evidence or eminence based?Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous CarcinomaAn open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma.Shave excision for basal cell carcinoma.Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.Basal cell carcinoma of the lip treated with radiotherapy.Updates on the Management of Non-Melanoma Skin Cancer (NMSC).Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers.Neoplasms
P2860
Q24677030-0AD30C3C-CE36-4BC3-B7F2-981AECB485CBQ33750383-633F593F-F60F-4713-A050-F8A95C535B54Q33862259-968E8A45-C034-4D89-AE57-5811BE4B4163Q34238132-6B62FB3A-410A-49B3-B2FB-905A24D7F6A1Q34370802-FB801682-A382-42AE-B085-35FD2F9FDDBEQ34423090-44821BC2-8451-439D-AC2C-5B7C334F1805Q34609416-151C2F07-C199-4F6E-9A7C-A412219EDDE8Q35094528-1C21E016-0729-44C1-B1FA-95C00557A1AEQ35101556-049CBF11-38D6-46E9-A01A-DC4461DE4E6DQ35822379-447406C4-9BDC-4908-9F0D-54C0C9FAE73AQ35843831-4CC7E32C-3B7F-4E3F-9610-CA4475CD6155Q36335269-C058E3EF-F1EA-467D-BE5B-0AA81A0F834AQ36478773-E8027067-B302-4698-A2D7-B73CB54A0B18Q36690495-5F5D797E-5207-441C-838B-EA5984B88FBEQ37204336-BA9DB3BE-E3D7-4EDD-99EE-3852AF7EFC0DQ37815382-0E476338-88A4-4938-A115-ACF85E796C71Q37877283-42C962A0-6EFB-4AE8-B3F7-B8E9AE0D07FCQ38602574-5C23974C-9349-47FB-B828-9133C69DBC60Q38731383-CC57C3E8-FB83-4355-AE15-FD99CFC5BA9AQ40913976-989017E7-CD8A-4CCB-8D83-3F58CA36DEFEQ41673878-4F967273-505C-4842-ACB5-A95068022071Q42436735-3167E22B-7AB1-4F53-9580-B3E9503F6671Q42452180-E1EBBD36-FB75-4A0A-A36D-DC274A1591B0Q42461734-653C9965-1F70-4BCF-9974-614E060ADD7CQ42472592-173808AE-F7E4-4EE8-9B32-FF734B831763Q42477190-93141BC4-E561-41E7-A31B-B9228B013A6AQ42480676-E7B68E52-89C3-4471-AA19-C66437CA7F7AQ42482103-8E6584FC-7583-493A-83C0-76C311B23304Q42489119-1E522411-2465-4E3F-9DE9-64CAFE48047DQ42493737-798FB24A-FF08-421B-A75F-1532B42EF5D4Q42500635-A26C0EB4-3FAE-47FB-8E28-FD471599408CQ42517502-C5F60610-1E6B-4677-8F49-41F7ACCAE110Q42517998-02B0E5A7-A4FA-4B89-AA29-A5FC29059E3FQ46811811-447017F8-9C39-43B8-B5C9-BFB04B4273FAQ52742485-7033C91E-2D87-454E-A6C3-7C228ECEA615Q56828372-84BB71A1-CF55-441D-9C09-DA5CBF7E3439
P2860
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@en
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@nl
type
label
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@en
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@nl
prefLabel
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@en
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@nl
P2093
P2860
P1476
Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
@en
P2093
P2860
P304
P356
10.1111/J.1524-4725.1991.TB03425.X
P577
1991-09-01T00:00:00Z